|Articles|July 1, 2015
Addressing Pharma Industry Issues
Richard Johnson, President and CEO of the Parenteral Drug Association (PDA) speaks with Biopharm International.
Advertisement
Richard Johnson, President and CEO of the Parenteral Drug Association (PDA) spoke with BioPharm International about drug shortages, manufacturing challenges, and industry issues.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Novartis Calls for Global Governments to Address Global Trade Policy
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
4
Generative AI and Adaptive Trials Shape Future Biotech Development
5